144 related articles for article (PubMed ID: 8104220)
1. Regulation of hapten-specific memory IgE responses induced in vitro. Requirement for both Thy-1+ AsGM1+ and Thy-1+ AsGM1- cells and for IFN-alpha and IL-4.
Herrick CA; Carucci JA; Kleiner GI; Durkin HG
J Immunol; 1993 Oct; 151(7):3440-9. PubMed ID: 8104220
[TBL] [Abstract][Full Text] [Related]
2. Origin and fate of IgE-bearing lymphocytes. II. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-keyhole limpet hemocyanin by various routes: relation to asialo GM1 ganglioside+ cells and IgE/CD23 immune complexes.
Auci DL; Chice SM; Heusser C; Athanassiades TJ; Durkin HG
J Immunol; 1992 Oct; 149(7):2241-8. PubMed ID: 1388186
[TBL] [Abstract][Full Text] [Related]
3. Control of IgE responses. III. IL-6 and IFN-alpha are isotype-specific regulators of peak BPO-specific IgE antibody-forming cell responses in mice.
Auci DL; Kleiner GI; Chice SM; Dukor P; Durkin HG
Clin Immunol Immunopathol; 1993 Mar; 66(3):219-24. PubMed ID: 8432046
[TBL] [Abstract][Full Text] [Related]
4. IL-6 mediated isotype specific suppression of hapten specific IgE in serum of BPO-KLH sensitized mice: role of IFN alpha in maintainance of hapten specific IgE responses.
Auci DL; Miller H; Chice SM; Durkin HG
Immunol Invest; 1994 Apr; 23(3):213-21. PubMed ID: 8070849
[TBL] [Abstract][Full Text] [Related]
5. Peyer's patches and mesenteric lymph nodes are the sites of first appearance of IgE bearing B lymphocytes and hapten specific IgE antibody forming cells in BPO-KLH sensitized mice.
Auci DL; Chice SM; Heusser C; Athanassiades TJ; Durkin HG
Reg Immunol; 1992; 4(4):216-24. PubMed ID: 1476874
[TBL] [Abstract][Full Text] [Related]
6. The development of IgE+ memory B cells following primary IgE immune responses.
Le Gros G; Schultze N; Walti S; Einsle K; Finkelman F; Kosco-Vilbois MH; Heusser C
Eur J Immunol; 1996 Dec; 26(12):3042-7. PubMed ID: 8977302
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. II. Mechanisms of substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vitro.
Carucci JA; Herrick CA; Durkin HG
J Neuroimmunol; 1994 Jan; 49(1-2):89-95. PubMed ID: 7507499
[TBL] [Abstract][Full Text] [Related]
8. Control of IgE responses. V. Oral administration of a synthetic derivative of the inner bacterial cell wall (SDZ 280.636) to sensitized mice induces isotype specific suppression of peak hapten specific IgE antibody forming cell responses, serum IgE levels and immediate hypersensitivity responses.
Auci DL; Kleiner GI; Chice SM; Athanassiades TJ; Dukor P; Durkin HG
Immunol Invest; 1998; 27(1-2):105-20. PubMed ID: 9561922
[TBL] [Abstract][Full Text] [Related]
9. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
10. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 and interleukin-4 have similar effects on hapten-specific primary antibody responses to penicillin in vivo.
Kerdine S; Pallardy M; Lamanètre S; Bertoglio J; Lebrec H
Eur J Immunol; 1996 Dec; 26(12):2890-4. PubMed ID: 8977282
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline-mediated IgE isotype-specific suppression of ongoing human and murine IgE responses in vivo and murine memory IgE responses induced in vitro.
Joks R; Smith-Norowitz T; Nowakowski M; Bluth MH; Durkin HG
Int Immunol; 2010 Apr; 22(4):281-8. PubMed ID: 20181654
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced suppression and potentiation of hapten-specific immediate hypersensitivity responses.
Auci DL; Kleiner G; Sheikh A; Acosta E; Athanassiadies TJ; Murali MR; Durkin HG
Immunol Invest; 1993 Apr; 22(3):205-18. PubMed ID: 7685321
[TBL] [Abstract][Full Text] [Related]
14. An in vitro murine model of a penicillin specific IgE anamnestic response.
Smith MC; Heusser C; Wagner K; Blaser K; Durkin HG
J Immunol Methods; 1990 Jul; 131(1):55-64. PubMed ID: 2380568
[TBL] [Abstract][Full Text] [Related]
15. Control of IgE responses. 4. Isotype-specific suppression of peak BPO-specific IgE antibody-forming cell responses and of BPO-specific IgE in serum by muramyldipeptide or murabutide after administration to mice by gavage.
Auci DL; Carucci JA; Chice SM; Smith MC; Dukor P; Durkin HG
Int Arch Allergy Immunol; 1993; 101(2):167-76. PubMed ID: 8508053
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro.
Carucci JA; Auci DL; Herrick CA; Durkin HG
J Leukoc Biol; 1995 Jan; 57(1):110-5. PubMed ID: 7530276
[TBL] [Abstract][Full Text] [Related]
17. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Durkin HG; Smith-Norowitz TA
Hum Immunol; 2005 Oct; 66(10):1029-38. PubMed ID: 16386644
[TBL] [Abstract][Full Text] [Related]
18. Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo.
van Ommen R; Vredendaal AE; Savelkoul HF
Eur J Immunol; 1994 Jun; 24(6):1396-403. PubMed ID: 8206100
[TBL] [Abstract][Full Text] [Related]
19. IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304).
Brummer E; Hanson LH; Stevens DA
Cell Immunol; 1993 Jul; 149(2):258-67. PubMed ID: 7687197
[TBL] [Abstract][Full Text] [Related]
20. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
